06
Aug
A federal court in Virginia ruled that the Food and Drug Administration’s (FDA) restrictions on the abortion pill mifepristone are unjustified and baseless, and ordered the agency to reconsider them. In its ruling, the court said the FDA disregarded the scientific record demonstrating that mifepristone could be safely prescribed without restrictive regulations.
